CD24 and melanoma: Monitored CSCs-surface markers, associated with stemness, resistance, tumor progression, adhesion, and invasion, were find to be not significantly up- or downregulated and TNFα makes cells only slightly more positive for these markers (CD166 and CD271 in melanoma; CD24 and CD26 in carcinoma) (Additional file 3).